Parkinson’s disease (PD) and dementia with Lewy bodies are currently defined by clinical features, which can be heterogeneous and do not capture the presymptomatic phase of […]

First Nations patients in Canada appear to be diagnosed with certain cancers at younger ages and later stages than other Canadians, which could indicate a need […]

AMSTERDAM — Experts at HLTH Europe 2024 told conference participants that “digital biomarkers” are on the horizon. Industry experts explained at a session on June 19 […]

Armed with $1 billion donation from media titan Mike Bloomberg, Johns Hopkins University, Baltimore, is joining the small but growing number of medical schools that have […]

More than a decade after bedaquiline (Sirturo) received an accelerated approval status for the treatment of multidrug-resistant pulmonary tuberculosis, the US Food and Drug Administration (FDA) […]

Eribulin seems to be an equally effective chemotherapy to pair with a dual HER2 blockade as taxane as first-line treatment for women with HER2-positive, locally advanced […]